Brief: Citius Pharmaceuticals Says Dr Reddy's Agreed To Partial Deferral Without Penalty Of Milestone Payment By Citius Oncology
13/09/2024 15:22
Sept 13 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS - DR. REDDY'S AGREED TO PARTIAL
DEFERRAL
WITHOUT PENALTY OF MILESTONE PAYMENT BY CITIUS ONCOLOGY INC
* CITIUS PHARMACEUTICALS INC - CO IS GUARANTOR OF
OBLIGATIONS OF
CITIUS ONCOLOGY, INC UNDER ASSET PURCHASE AGREEMENT
Source text for Eikon: ID:n0001213900-24-078288
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules